These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34017828)

  • 21. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of highly branched cyclic dextrin in inhalable particles of combined antibiotics for the pulmonary delivery of anti-tuberculosis drugs.
    Kadota K; Senda A; Tagishi H; Ayorinde JO; Tozuka Y
    Int J Pharm; 2017 Jan; 517(1-2):8-18. PubMed ID: 27913241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin.
    Kadota K; Yanagawa Y; Tachikawa T; Deki Y; Uchiyama H; Shirakawa Y; Tozuka Y
    Int J Pharm; 2019 Jan; 555():280-290. PubMed ID: 30471373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Design of Spray-dried Porous Particles for Sugar-based Dry Powder Inhaler Formulation].
    Kadota K
    Yakugaku Zasshi; 2018; 138(9):1163-1167. PubMed ID: 30175760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines.
    Guo Y; Bera H; Shi C; Zhang L; Cun D; Yang M
    Acta Pharm Sin B; 2021 Aug; 11(8):2565-2584. PubMed ID: 34522598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of Vancomycin-Loaded Aerogels Implementing Inkjet Printing and Superhydrophobic Surfaces.
    Remuiñán-Pose P; López-Iglesias C; Iglesias-Mejuto A; Mano JF; García-González CA; Rial-Hermida MI
    Gels; 2022 Jul; 8(7):. PubMed ID: 35877502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled dry powder formulations for treating tuberculosis.
    Das S; Tucker I; Stewart P
    Curr Drug Deliv; 2015; 12(1):26-39. PubMed ID: 25030114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
    Koushik K; Dhanda DS; Cheruvu NP; Kompella UB
    Pharm Res; 2004 Jul; 21(7):1119-26. PubMed ID: 15290850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dry powder inhalation: past, present and future.
    de Boer AH; Hagedoorn P; Hoppentocht M; Buttini F; Grasmeijer F; Frijlink HW
    Expert Opin Drug Deliv; 2017 Apr; 14(4):499-512. PubMed ID: 27534768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Devices for dry powder drug delivery to the lung.
    Berkenfeld K; Lamprecht A; McConville JT
    AAPS PharmSciTech; 2015 Jun; 16(3):479-90. PubMed ID: 25964142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S; Schoenbrodt T; Weiler C; Friess W
    Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine serum albumin as a lyoprotectant for preparation of DNA dry powder formulations using the spray-freeze drying method.
    Tsukamoto M; Okuda T; Okamoto H; Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Biol Pharm Bull; 2012; 35(7):1178-81. PubMed ID: 22791169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View.
    Zellnitz S; Roblegg E; Pinto J; Fröhlich E
    Curr Drug Deliv; 2019; 16(3):180-194. PubMed ID: 30360739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel approach for real-time monitoring of carrier-based DPIs delivery process
    Zhang X; Cui Y; Liang R; Wang G; Yue X; Zhao Z; Huang Z; Huang Y; Geng J; Pan X; Wu C
    Acta Pharm Sin B; 2020 Jul; 10(7):1331-1346. PubMed ID: 32874832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of surface characteristics of modified glass beads as model carriers in dry powder inhalers (DPIs) on the aerosolization performance.
    Zellnitz S; Schroettner H; Urbanetz NA
    Drug Dev Ind Pharm; 2015; 41(10):1710-7. PubMed ID: 25632978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dry powder inhalers for optimal drug delivery.
    Newman SP
    Expert Opin Biol Ther; 2004 Jan; 4(1):23-33. PubMed ID: 14680466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
    Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry powder inhalers: an overview.
    Atkins PJ
    Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dry powders for oral inhalation free of lactose carrier particles.
    Healy AM; Amaro MI; Paluch KJ; Tajber L
    Adv Drug Deliv Rev; 2014 Aug; 75():32-52. PubMed ID: 24735676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.